Real advantages of preservative-free preparations in special containers for long-term glaucoma therapy

Acta Ophthalmologica Scandinavica, Supplement

Volumn 80, Issue 236, 2002, Pages 57-59

  Boles Carenini, B ^a   Boldrini, E ^a   Brogliatti, B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; ANTIHYPERTENSIVE AGENT; BENZALKONIUM CHLORIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; EYE DROPS; FAS ANTIGEN; PRESERVATIVE; BENZALKONIUM; TIMOLOL;

APOPTOSIS; ARTICLE; CELL DEATH; CONTAINER; CONTROLLED STUDY; DRUG FORMULATION; GLAUCOMA; HUMAN; IMMUNOSTIMULATION; INFLAMMATORY INFILTRATE; LONG TERM CARE; PRIORITY JOURNAL; PROTEIN EXPRESSION; BACTERIUM; DRUG CONTAMINATION; DRUG PACKAGING; DRUG STABILITY; DRUG STORAGE; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION;

ANTIHYPERTENSIVE AGENTS; BACTERIA; BENZALKONIUM COMPOUNDS; DRUG COMPOUNDING; DRUG CONTAMINATION; DRUG PACKAGING; DRUG STABILITY; DRUG STORAGE; GLAUCOMA; HUMANS; OPHTHALMIC SOLUTIONS; PRESERVATIVES, PHARMACEUTICAL; TIMOLOL;

EID: 0036031148     PISSN: 13953931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Baudouin C, Pisella PJ, Fillacier K, Goldschil M, Becquet F, De Saint Jean M & Bechetoille A (1999): Ocular surface inflammatory changes induced by topical antiglaucoma drugs. Ophthalmology 106: 556-563.
2. Becquet F, Goldschild H, Holdovan MS, Ettaiche M, Gastand P & Baudouin C (1998): Histopathological effects of topical ophthalmic preservatives on rat cornea conjunctival surface. Curr Eye Res 17: 419-425.
3. Chang L, Crowston JG, Cordeiro MF, Akbar AN & Khaw PT (2000): The role of the immune system in conjunctival wound healing after glaucoma surgery. Surv Ophthalmol 45: 49-68.
4. De Saint Jean M, Debbasch C, Brignole F, Rat P, Warnet JM & Baudouin C (2000): Toxicité des collyres beta-bloquants avec ou sans conservateur dans un model in vitro de cellules conjuctivales humaines. J Fr Ophthalmol 23: 111-121.
5. Debbasch C, Brignole F, Pisella P-J, Warnet J-M, Rat P & Baudouin C (2001): Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells. Invest Ophthalmol Vis Sci 42: 642-652.
6. Debbasch C, Rap P, Warnet JM, De Saint Jean M, Baudoin C & Pisella PJ (2000): Evaluation of the toxicity of benzalkonium chloride on the ocular surface. J Toxicol Cut Ocular Toxicol 19: 105-115.
7. Feher JM, Scuderi GL, Librando A, Messina A, Cafa F & Librando G (1990): Effeti a lungo termine dei beta-bloccanti senza conservanti sulla superficie corneale del coniglio. Uno studio ultrastrutturale. Clin Ocul 4: 261-265.
8. Kuppens FVMJ, de Jon CA, Thorsten RS, de Keizer RJW & van Best JA (1995): Effect of timolol with and without preservative on the basal tear turnover in glaucoma. Br J Ophthalmol 79: 339-342.
9. Lavin MJ, Wormald RPL, Migdal CS & Hitchings RA (1990): The influence of prior therapy on the success of trabeculectomy. Arch Ophthlamol 108: 1543-1550.
10. Olson RJ & White GI (1990): Preservatives in ophthalmic topical medications: a significant cause of disease. Cornea 9: 363-364.
11. Van Santvliet L, Sam T & Ludwig A (1996): Packaging of ophthalmic solutions: influence on stability, sterility, eye drops instillation and patient compliance. Eur J Biopharm 42: 375-384.